{{Benzos}}
The below tables contain a '''sample list of benzodiazepines''' that are commonly prescribed, with their basic [[pharmacological]] characteristics such as half-life and equivalent doses to other [[benzodiazepines]] also listed, along with their trade names and primary uses. The [[elimination half-life]] is how long it takes for half of the drug to be eliminated by the body. "Time to peak" refers to when maximum levels of the drug in the blood occur after a given dose. Benzodiazepines generally share the same pharmacological properties, such as [[anxiolytic]], [[sedative]], [[hypnotic]], [[skeletal muscle relaxant]], [[amnesic]] and [[anticonvulsant]] (hypertension in combination with other anti hypertension medications). Variation in potency of certain effects may exist among individual benzodiazepines. Some benzodiazepines produce [[active metabolites]]. Active metabolites are produced when a person's body metabolizes the drug into compounds that share a similar pharmacological profile to the parent compound and thus are relevant when calculating how long the pharmacological effects of a drug will last. Long-acting benzodiazepines with long-acting active metabolites such as [[diazepam]] and [[chlordiazepoxide]] are often prescribed for benzodiazepine or alcohol withdrawal or for [[anxiety]] if constant dose levels are required throughout the day. Shorter-acting benzodiazepines are often preferred for [[insomnia]] due to their lesser hangover effect.<ref>{{cite journal |author=Golombok S, Lader M |title=The psychopharmacological effects of premazepam, diazepam and placebo in healthy human subjects |journal=Br J Clin Pharmacol |volume=18 |issue=2 |pages=127–33 |year=1984 |month=August |pmid=6148956 |pmc=1463527 |doi= }}</ref><ref>{{cite journal |author=de Visser SJ, van der Post JP, de Waal PP, Cornet F, Cohen AF, van Gerven JM |title=Biomarkers for the effects of benzodiazepines in healthy volunteers |journal=Br J Clin Pharmacol |volume=55 |issue=1 |pages=39–50 |year=2003 |month=January |pmid=12534639 |pmc=1884188 |doi= 10.1046/j.1365-2125.2002.t01-10-01714.x|url=http://www3.interscience.wiley.com/cgi-bin/fulltext/118882375/PDFSTART?CRETRY=1&SRETRY=0 |format=PDF}}</ref><ref>{{cite web| url= http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html| title=Benzodiazepine Names| accessdate=2009-04-05| publisher=non-benzodiazepines.org.uk}}</ref><ref>{{cite web |author = C. Heather Ashton | title = Benzodiazepine Equivalence Table | url = http://www.benzo.org.uk/bzequiv.htm | publisher = benzo.org.uk | year = 2007 | month = March | accessdate = 2009-04-05}}</ref><ref>{{cite web | last = Bob | first = Dr | title = Benzodiazepine Equivalence Charts | url = http://www.dr-bob.org/tips/bzd.html | publisher = dr-bob.org | year = 1995 | month = July | accessdate = 2009-04-05}}</ref>

It is important to note that the [[elimination half-life]] of diazepam and chlordiazepoxide as well as other long half-life benzodiazepines is twice as long in the elderly compared to younger individuals. Individuals with an impaired liver also metabolise benzodiazepines more slowly. Many doctors{{Who?|date=March 2013}} make the mistake of not adjusting benzodiazepine dosage according to age in elderly patients. Thus the approximate equivalent doses below may need to be adjusted accordingly in individuals on short acting benzodiazepines who metabolise long-acting benzodiazepines more slowly and vice versa. The changes are most notable with long acting benzodiazepines as these are prone to significant accumulation in such individuals.{{Cite quote|date=March 2013}}  For example the equivalent dose of diazepam in an elderly individual on lorazepam may be up to half of what would be expected in a younger individual.<ref>{{cite book |last1=Salzman |first1=Carl |title=Clinical geriatric psychopharmacology |url=http://books.google.com/?id=RXvpjJ1Un2gC |edition=4th |date=15 May 2004 |publisher=Lippincott Williams & Wilkins |location=USA |isbn=978-0-7817-4380-8 |pages=450–453}}</ref><ref>{{cite journal |doi=10.2165/00002018-200528060-00005 |author=Delcò F, Tchambaz L, Schlienger R, Drewe J, Krähenbühl S |title=Dose adjustment in patients with liver disease |journal=Drug Saf |volume=28 |issue=6 |pages=529–45 |year=2005 |pmid=15924505 }}</ref> Equivalencies between individual benzodiazepines can differ by 400 fold on a mg per mg basis; awareness of this fact is necessary for the safe and effective use of benzodiazepines.<ref>{{Cite journal | last1 = Riss | first1 = J. | last2 = Cloyd | first2 = J. | last3 = Gates | first3 = J. | last4 = Collins | first4 = S. | title = Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. | journal = Acta Neurol Scand | volume = 118 | issue = 2 | pages = 69–86 | month = Aug | year = 2008 | doi = 10.1111/j.1600-0404.2008.01004.x | pmid = 18384456 }}</ref>
<br>
==Dose equivalency table==
<br>
'''* Citation needed for this table.''' 
{| class="wikitable sortable" style="float:center; margin-left:3px;text-size:100%; text-align:right"
|-
|'''Drug Name''' || '''Common Brand Names*'''||'''Time to Peak (Onset of action in hours)'''||'''[[elimination half-life|Elimination Half-Life]] ([[Hour|h]])<sup>†</sup> [active metabolite]'''|| '''Therapeutic use''' || '''Approximate Equivalent Dose<sup>‡</sup>'''
|-
|[[Alprazolam]] ||Helex, Xanax, Xanor, Onax, Alprox, Restyl, Tafil, Paxal||1-2||9–20 hours ||[[anxiolytic]]||0.5&nbsp;mg
|-
|[[Bretazenil]]<ref>{{cite journal | doi= 10.1046/j.1365-2125.1996.38514.x | author= van Steveninck AL ''et al.''| title= Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol. | journal=British Journal of Clinical Pharmacology | year=1996 | volume=41 | pages=565–573 | pmid= 8799523 | issue= 6 | pmc= 2042631}}</ref> ||N/A||?||2.5 hours ||[[anxiolytic]], [[anticonvulsant]]||0.5&nbsp;mg
|-
|[[Bromazepam]] ||Lectopam, Lexotanil, Lexotan, Bromam||1-3||10–20 hours||[[anxiolytic]]||5-6&nbsp;mg
|-
|[[Brotizolam]]||Lendormin, Dormex, Sintonal, Noctilan||0.5-2||4–5 hours||[[hypnotic]]||0.25&nbsp;mg
|-
|[[Chlordiazepoxide]]||Librium, Risolid, Elenium||1.5-4||5–30 hours [36–200 hours]||[[anxiolytic]]||25&nbsp;mg
|-
|[[Cinolazepam]]||Gerodorm||0.5-2||9 hours||[[sedative]]||40&nbsp;mg
|-
|[[Clonazepam]]||Rivotril, Klonopin,Iktorivil, Paxam||1-4
||18–50 hours||[[anxiolytic]], [[anticonvulsant]]|||0.5&nbsp;mg
|-
|[[Clorazepate]] ||Tranxene, Tranxilium||Variable||36–100 hours||[[anxiolytic]], [[anticonvulsant]]||15&nbsp;mg
|-
|[[Clotiazepam]] ||Veratran, Clozan, Rize||1-3||6-18 hours||[[anxiolytic]]||5-10&nbsp;mg
|-
|[[Cloxazolam]] ||Sepazon, Olcadil||2-5 (?)||18–50 hours||[[anxiolytic]], [[anticonvulsant]]||1&nbsp;mg
|-
|[[Delorazepam]] ||Dadumir||1-2||60–140 hours||[[anxiolytic]]||1&nbsp;mg
|-
|[[Diazepam]] ||Antenex, Apaurin, Apzepam, Apozepam, Hexalid, Pax, Stesolid, Stedon, Valium, Vival, Valaxona||1-1.5||20–100 hours [36-200]||[[anxiolytic]], [[anticonvulsant]], [[muscle relaxant]]||10&nbsp;mg
|-
|[[Estazolam]] ||ProSom||1-5||10–24 hours||[[hypnotic]]||2&nbsp;mg
|-
|[[Etizolam]] ||Etilaam, Pasaden, Depas||1-2||6 hours||[[anxiolytic]], [[hypnotic]]||1&nbsp;mg
|-
|[[Ethyl loflazepate]] ||Victan, Meilax, Ronlax||1.5||50-100 hours||[[anxiolytic]]||2&nbsp;mg
|-
|[[Flunitrazepam]] ||Rohypnol, Hipnosedon, Vulbegal, Fluscand, Flunipam, Ronal, Rohydorm,||0.5-3||18–26 hours [36–200 hours]||[[hypnotic]]||1&nbsp;mg
|-
|[[Flurazepam]] ||Dalmadorm, Dalmane||1-1.5||40–250 hours||[[hypnotic]]||15–30&nbsp;mg
|-
|[[Flutoprazepam]] ||Restas||0.5-9||60–90 hours||[[hypnotic]], [[anticonvulsant]]||2–3&nbsp;mg
|-
|[[Halazepam]] ||Paxipam||1-3||30–100 hours||[[anxiolytic]]||20–40&nbsp;mg
|-
|[[Ketazolam]] ||Anxon||2.5-3||30–100 hours [36-200] ||[[anxiolytic]]||15–30&nbsp;mg
|-
|[[Loprazolam]] ||Dormonoct||0.5-4||6–12 hours||[[hypnotic]]||1-2&nbsp;mg
|-
|[[Lorazepam]] ||Ativan, Lorenin, Lorsilan, Temesta, Tavor, Lorabenz||2-4||10–20 hours||[[anxiolytic]], [[anticonvulsant]]|| 1mg
|-
|[[Lormetazepam]] ||Loramet, Noctamid, Pronoctan||0.5-2||10–12 hours||[[hypnotic]]||1.5&nbsp;mg
|-
|[[Medazepam]] ||Nobrium||?||36–200 hours||[[anxiolytic]]||10&nbsp;mg
|-
|[[Midazolam]]|| Dormicum, Versed, Hypnovel, Dormonid||0.5-1||3 hours (1.8–6 hours) ||[[hypnotic]], [[anticonvulsant]]||7.5&nbsp;mg
|-
|[[Nimetazepam]] ||Erimin||0.5-3||14–30 hours||[[hypnotic]]||5&nbsp;mg
|-
|[[Nitrazepam]] ||Mogadon, Alodorm, Pacisyn, Dumolid, Nitrazadon||0.5-7||15–38 hours||[[hypnotic]], [[anticonvulsant]]||10&nbsp;mg
|-
|[[Nordazepam]] ||Madar, Stilny||?||50–120 hours||[[anxiolytic]]||10&nbsp;mg
|-
|[[Oxazepam]]||Seresta, Serax, Serenid, Serepax, Sobril, Oxabenz, Oxapax, opamox ||3-4||4–15 hours ||[[anxiolytic]]||20&nbsp;mg
|-
|[[Phenazepam]]|| Phenazepam||1.5-4 ||60 hours ||[[anxiolytic]], [[anticonvulsant]]||1&nbsp;mg
|-
|[[Pinazepam]] ||Domar||?||40–100 hours||[[anxiolytic]]||20&nbsp;mg
|-
|[[Prazepam]] ||Lysanxia, Centrax||2-6||36–200 hours||[[anxiolytic]]||20&nbsp;mg
|-
|[[Premazepam]] ||N/A||2-6||10–13 hours||[[anxiolytic]]||15&nbsp;mg
|-
|[[Pyrazolam]] ||N/A||1-1.5||9–11 hours||[[anxiolytic]]||1.0&nbsp;mg
|-
|[[Quazepam]] ||Doral||1-5||39–120 hours||[[hypnotic]]||20&nbsp;mg
|-
|[[Temazepam]]||Restoril, Normison, Euhypnos, Temaze, Tenox||0.5-3||8–22 hours||[[hypnotic]]||20&nbsp;mg
|-
|[[Tetrazepam]]||Myolastan||1-3|| 3–26 hours ||[[Skeletal muscle relaxant]]||100&nbsp;mg
|-
|[[Triazolam]]||Halcion, Rilamir||0.5-2||2 hours ||[[hypnotic]]||0.25&nbsp;mg
|} 
<br>
===Atypical benzodiazepine receptor ligands===

{| class="wikitable" style="float:center; margin-left:3px;text-size:100%; text-align:right"
|-
|'''Drug Name''' || '''Common Brand Names*'''||'''[[elimination half-life|Elimination Half-Life]] ([[Hour|h]])<sup>†</sup> [active metabolite]'''|| '''Primary Effects''' || '''Approximate Equivalent Dose<sup>‡</sup>'''
|-
|[[Clobazam]] ||Frisium, Urbanol||8–60 hours||[[anxiolytic]], [[anticonvulsant]]|| 20&nbsp;mg
|-
|[[DMCM]] || ? || ? ||[[anxiogenic]], [[convulsant]] || Non-applicable
|-
|[[Flumazenil]] || Anexate, Lanexat, Mazicon, Romazicon || 1 hour || [[antidote]] || Typical dose 0.2 - 0.6&nbsp;mg<sup>ð</sup>
|-
|[[Eszopiclone]]<sup>§</sup> || Lunesta || 6 hours || [[hypnotic]] || 3&nbsp;mg
|-
|[[Zaleplon]]<sup>§</sup> || Sonata, Starnoc || 1 hours || [[hypnotic]] || 20&nbsp;mg
|-
|[[Zolpidem]]<sup>§</sup> || Ambien, Nytamel, Sanval, Stilnoct, Stilnox, Xolnox, Zoldem, Zolnod || 2.6 hours || [[hypnotic]] || 20&nbsp;mg
|-
|[[Zopiclone]]<sup>§</sup> || Imovane, Rhovane, Ximovan; Zileze; Zimoclone; Zimovane; Zopitan; Zorclone, || 4–6 hours || [[hypnotic]] || 15&nbsp;mg
|}
<br>
<nowiki>*</nowiki> Not all trade names are listed.  Click on drug name to see a more comprehensive list.
* Equivalent doses are based on clinical experience but may vary between individuals. http://www.benzo.org.uk/bzequiv.htm. ('''Note:''' The lack of neutrality regarding the viewpoints listed on www.benzo.org.uk where the Ashton Manual is hosted should be considered by readers before any information is erroneously mistaken as factual and without doubt or biases.  Ray Nimmo, the owner of www.benzo.org.uk, has called the repeat prescribing of benzodiazeines a "Benzo Scandal".  See sub-topic "Controversy" for clarification.)
<br>
<sup>‡</sup> Flumazenil is a imidazobenzodiazepine derivative<ref> http://www.gene.com/download/pdf/romazicon_prescribing.pdf</ref> and in layman's terms, it is a benzodiazepine overdose antidote which is given intravenously in Intensive Care Units (ICU's) to reverse the effects of benzodiazepines overdoses, as well for overdoses of the non-benzodiazepine "Z-drugs" such as Ambien and Lunesta. <ref>http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=75307</ref> '''Flumazenil is contraindicated for benzodiazepine-tolerant patients''' in overdose cases.<ref>http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=59847#i4i_warnings_id_416886b7-3454-4783-bfc4-0864d4d43467</ref> In such cases, the risks far outweigh the benefits, which include potential and severe seizures.<ref>Gary R. Fleisher; Stephen Ludwig; Benjamin K. Silverman (2002). Synopsis of pediatric emergency medicine. Lippincott Williams & Wilkins. pp 409. ISBN 978-0-7817-3274-1. Retrieved 3/22/2013.</ref><ref>http://www.gene.com/download/pdf/romazicon_prescribing.pdf</ref> The methods by which Flumazenil acts to prevent non-benzodiazepine tolerant overdose from causing potential harm is via preventing the benzodiazepines and Z-drugs from binding to the GABA<sub>A</sub> receptors via competitive inhibition which the Flumazenil creates. Clinical observation notating the patient's oxygen levels, respiratory, heart and blood pressure rates are used, as they are much safer than the potential seizure effects from Flumazenil. Supportive care to mediate any problems resulting from abnormal rates of the pulmonary, respiratory and cardiovascular systems are typically the only treatments that are required in benzodiazepine-only overdoses.<ref> http://www.inchem.org/documents/pims/pharm/pim181.htm#DivisionTitle:8.1.1.1  Toxicological analyses. Retrieved 3/21/2013.)</ref> In most cases, activated charcoal/carbon is often used to prevent benzodiazepines from being absorbed by the gastrointestinal tract, and the use of stomach-pumping/gastric lavage is no longer commonly used nor suggested by some toxicologists.<ref>Vale JA, Kulig K; American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. (2004). "Position paper: gastric lavage". J Toxicol Clin Toxicol 42 (7): 933–943. doi:10.1081/CLT-200045006. PMID 15641639 </ref> Even in cases where other central nervous system (CSN) depressants (such as in combined benzodiazepine and tricyclic antidepressant/TCA overdoses) are detected and/or suspected, endotrachial intubation for the airway path and supportive oxygen are typically implemented and are much safer than Flumazenil.<ref> http://www.inchem.org/documents/pims/pharm/pim181.htm#DivisionTitle:8.1.1.1  Toxicological analyses. Retrieved 3/21/2013.)</ref>  
<br>

===Controversy===
''The Ashton Manual'' claims the potency of both Alprazolam and Clonazepam to be 0.5 mgs to be equivalent to 10 mgs of Diazepam/Valium, when they have both long been known to be 1 mg.<ref>http://www.csam-asam.org/sites/default/files/pdf/misc/TIP_45.pdf, Page 76.  US Department of Health and Human Services, 2006. Retrieved 3/23/12.)</ref> Also compare the UK's ''Ashton Chart'' with the chart at http://www.psychresidentonline.com/Benzodiazepine%20Comparison.htm and one will see how the ''Ashton Chart'' does not represent a worldwide view on this topic.
<br>

Another chart with different ratios can be seen at https://docs.google.com/viewer?a=v&q=cache:kIztmpST_isJ:www.health.qld.gov.au/atod/documents/24904.pdf+&hl=en&gl=us&pid=bl&srcid=ADGEESgmtqb6fHK5OVeXBdK8Zi_hJvaAyLSvEYXO0_8Ojc9JixlkOEIztMkXSGfN_eyPTkEu8NFLuzZuOgf6nkgTgku9nbNj__s6nYv_aH-1ZNynIuO8ssp1sRY3TN4MNyDKoZOOTRkI&sig=AHIEtbRJIodYaXE41qdLwOxivtqUfjbS_Q; Table 11, Section 5.8. It notes that 10 mg of Valium is equivalent to 1 mg of Xanax/Alprazolam and .50- 1 mg of Klonopin/Clonazepam/Ritrovil. (Australian Department of Health)
<br>

The UK's House of Commons began APPGITA/The All Party Parliamentary Group on Involuntary Tranquilliser Addiction. Since 2002, APPGITA has tried to politically mandate prescribing guidelines for benzodiazepines.<ref>http://www.appgita.com/index.php/2002/11/early-day-motion-launched-18-november-2002/</ref> APPGITA has attempted to get a two to four week limit mandate for prescribing benzodiazepines to replace the two to four week benzodiazepine prescribing guidelines, which are merely recommended. <ref>http://www.appgita.com/index.php/2002/11/</ref><ref>http://www.benzo.org.uk/appg.htm</ref>

==See also==
*[[Benzodiazepine]]
*[[Benzodiazepine dependence]]
*[[Benzodiazepine withdrawal syndrome]]

==References==
{{Reflist|colwidth=30em}}

==Further reading==
*{{cite book |last1=Gitlow |first1=Stuart |title=Substance Use Disorders: A Practical Guide |url=http://books.google.com/?id=rbrSdWVerBUC |edition=2nd |date=1 October 2006 |publisher=Lippincott Williams and Wilkins |location=USA |isbn=978-0-7817-6998-3 |pages=110}}
*{{cite book |last1=Galanter |first1=Marc |last2=Kleber |first2=Herbert D. |title=The American Psychiatric Publishing Textbook of Substance Abuse Treatment |url=http://books.google.com/?id=6wdJgejlQzYC |edition=4th |date=1 July 2008 |publisher=American Psychiatric Publishing Inc |location=United States of America |isbn=978-1-58562-276-4 |page=216 |chapter= |chapterurl= }}

{{Benzodiazepines}}

[[Category:Benzodiazepines|*]]